Many proteins, such as DNA-binding proteins (DBPs, e.g. transcriptional factor c-myc) and RNA-binding proteins (RBPs, e.g. IGF2BPs), play important roles in cancer initiation and progression and are regarded as high-value therapeutic targets. This evidence concerns the gene MYC and cancer.